Effect of electroacupuncture on anti-Mullerian hormone expression in rats with polycystic ovarian syndrome

被引:1
|
作者
Zhou Jing [1 ]
Sun Yi [1 ,2 ]
Sun Jie
Zhao Ji-meng [1 ]
Cui Yun-hua [1 ]
Wu Ling-xiang [3 ]
Wu Huan-gan [1 ]
Shi Yin [1 ,3 ]
Li Liang [4 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shanghai 201203, Peoples R China
[2] Shanghai Songjiang Dist Cent Hosp, Shanghai 201600, Peoples R China
[3] Shanghai Res Inst Acupuncture & Meridian, Shanghai 200030, Peoples R China
[4] China Acad Chinese Med Sci, Beijing 100700, Peoples R China
关键词
Acupuncture Therapy; Electroacupuncture; Point; Zhongji (CV 3); Guanyuan (CV 4); Anti-Mullerian Hormone; Polycystic Ovary Syndrome; Follicle Stimulating Hormone; Rats; GRANULOSA-CELLS; WOMEN; AMH; ACUPUNCTURE; FSH; PATHOPHYSIOLOGY; STEROIDOGENESIS; ESTRADIOL; ESTROGEN; ARREST;
D O I
10.1007/s11726-019-1094-y
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
ObjectiveTo observe whether the effect of electroacupuncture (EA) on improving sex hormone disorders and follicle development is by decreasing the expression of anti-Mullerian hormone (AMH) in rats with experimental polycystic ovarian syndrome (PCOS).MethodsForty rats were randomly divided into four groups, a normal group (NG), a model group (MG), an EA at acupoints group (EAAG), and an EA at non-acupoints group (EANAG), with 10 rats in each group. The rats in the EAAG and EANAG were intervened by EA treatment for consecutive 14 d. Zhongji (CV 3) and Guanyuan (CV 4) were selected as the acupoints in the EAAG, and the tip of the tail and 1 cm up from the tail tip were selected as the non-acupoints in the EANAG. After treatment, the histomorphological changes of the ovary, the levels of aromatase P450 (P450arom), testosterone and estradiol in the ovarian tissues, and the expressions of follicle stimulating hormone (FSH) and AMH were observed.ResultsAfter treatment, compared with the MG and EANAG, the expression of AMH decreased (P<0.05), the levels of P450arom and estradiol increased significantly, and the level of testosterone decreased significantly (all P<0.01) in the EAAG. Additionally, several normal follicles were present and the number of cystically dilated follicles decreased in the EAAG. Compared with the MG and EANAG, the EAAG obviously had more follicular granulosa cells.ConclusionEA can down-regulate the abnormally increased expression of AMH to improve sex hormone disorders and follicle development in PCOS rats.
引用
收藏
页码:80 / 88
页数:9
相关论文
共 50 条
  • [31] Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome
    Zhang, Fan
    Liu, Xiao-ling
    Rong, Nan
    Huang, Xiao-wen
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2017, 37 (01) : 70 - 73
  • [32] Effect of anti-mullerian hormone on stem cell factor in serum, follicular fluid and ovarian granular cells of polycystic ovarian syndrome patients
    Zhang, J-F
    Yu, C-M
    Yan, L-L
    Ma, J-L
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (22) : 7877 - 7882
  • [33] Anti-Mullerian Hormone and Fertility Treatment Decisions in Polycystic Ovary Syndrome: A Literature Review
    Shah, Duru
    Jirge, Padma Rekha
    JOURNAL OF HUMAN REPRODUCTIVE SCIENCES, 2024, 17 (01) : 16 - 24
  • [34] Anogenital distance and anti-Mullerian hormone combined improves the diagnosis of polycystic ovary syndrome
    Prieto-Sanchez, Maria T.
    Hernandez-Penalver, Ana, I
    Sanchez-Ferrer, Maria L.
    Mendiola, Jaime
    Torres-Cantero, Alberto M.
    HUMAN FERTILITY, 2022, 25 (02) : 274 - 282
  • [35] Role of Anti-Mullerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review
    Dumont, Agathe
    Robin, Geoffroy
    Catteau-Jonard, Sophie
    Dewailly, Didier
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2015, 13
  • [36] Correlation between anti-mullerian hormone with insulin resistance in polycystic ovarian syndrome: a systematic review and meta-analysis
    Muslim, Mohd Zakwan Md
    Jelani, Aniza Mohammed
    Shafii, Noorazliyana
    Yaacob, Najib Majdi
    Soh, Noor Azlin Azraini Che
    Ibrahim, Hanim Afzan
    JOURNAL OF OVARIAN RESEARCH, 2024, 17 (01)
  • [37] Serum Anti-Mullerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms
    Ahmed, Nada
    Batarfi, Asma A.
    Bajouh, Osama S.
    Bakhashab, Sherin
    DIAGNOSTICS, 2019, 9 (04)
  • [38] Trends in anti-Mullerian hormone concentrations across different stages of pregnancy in women with polycystic ovary syndrome
    Koeninger, Angela
    Kampmeier, Antje
    Schmidt, Boerge
    Frank, Mirjam
    Strowitzki, Thomas
    Kimmig, Rainer
    Gellhaus, Alexandra
    Mach, Pawel
    REPRODUCTIVE BIOMEDICINE ONLINE, 2018, 37 (03) : 367 - 374
  • [39] Circulating Anti-Mullerian Hormone Levels in Daughters of Women with and without Polycystic Ovary Syndrome
    Olszanecka-Glinianowicz, Magdalena
    Zachurzok, Agnieszka
    Drosdzol-Cop, Agnieszka
    Bozetowicz-Wikarek, Maria
    Owczarek, Aleksander
    Gawlik, Aneta
    Chudek, Jerzy
    Skrzypulec-Plinta, Violetta
    Malecka-Tendera, Ewa
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 85 (06): : 372 - 378
  • [40] Pathogenic Anti-Mullerian Hormone Variants in Polycystic Ovary Syndrome
    Gorsic, Lidija K.
    Kosova, Gulum
    Werstein, Brian
    Sisk, Ryan
    Legro, Richard S.
    Hayes, M. Geoffrey
    Teixeira, Jose M.
    Dunaif, Andrea
    Urbanek, Margrit
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (08): : 2862 - 2872